(A Top Pick May 24/22, Up 1.6%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with ORCL has triggered its stop at $70. To remain disciplined, we recommend covering the position at this time.
(A Top Pick May 24/22, Up 12.1%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK is progressing well. We now recommend trailing up the stop (from $55) to $70.
She recently added Oracle. They continue to grow their cloud business, focusing on small/medium-sized businesses which may feel pressure in their spending in coming quarters. Absorbing Cerner may hurt margins given integration costs.
(A Top Pick May 08/20, Up 36%) He'd continue to own a small piece, but don't load up the truck. Bought back too much stock, so they blew out their equity on the balance sheet. Fundamentals are not as great now. If Fed turns around, this will do well.
Stockchase Research Editor: Michael O'Reilly The company's largest acquisition in its history at $28 billion, sets it up to make a major move in the healthcare sector. The company it acquired produces medical hardware and software for pharmacies and labs and has been consistently profitable. Analysts believe this will allow ORCL to move from trading with its peers at 26x earnings, to next year be 13x and management noted revenue growth was the highest it has been since entering into the cloud space. We recommend a stop loss at $55, looking to achieve $93.50 -- upside over 35%. Yield 1.83%. (Analysts’ price target is $93.19)
Lots of horses in the stable. 12-month price target of $105.25. It has come down, but not as much as the market. Buy in thirds here at $69, 66, and 62-63.
Allan Tong’s Discover Picks I see the recent dip as a buying opportunity. Nothing broken here. Oracle trades at 25.5x earnings, which lower than Apple's or Microsoft's and half of Adobe's 52x. True, its ROI of 11.69% lags Adobe's 24.68% and Intuit's 20.62%. However, Oracle is a relatively safe tech stock, because it benefits from recurring revenues and remains profitable. True, they got into the cloud computing game late, but this division is now showing legs. You can buy Oracle and sleep well. It pays a 1.46% dividend, safe at a 32.78% payout ratio. Read 3 Technology Stocks with Potential for our full analysis.
Tech names with real earnings will and are beating those based only on sales or speculation. You want boring, old tech companies and could thrive this year. After years of middling performance, it broke out in 2021. Still cheap at 18x PE. Reported last month a monster earnings beat and great guidance. Cloud business is on fire, but overlooked. Their old-school database business is doing well. Rallied 15% in response, but then they bought an electronics health record company which erased that gain. Wall Street is wrong; it's a good deal for Oracle. Buy this pullback.
Oracle is profitable, has defensive growth and is less cyclical, because many of its sales/revenues are recurring. Their recent acquisition was good. Also, the stock has been beaten up, so it's now a good entry point. The dinosaur tech names are worthy.
Price has retreated in last little while, almost 20%. Fantastic opportunity to buy. Bought Cerner for 28B, a leader in healthcare IT providers and a rich cash cow. Market cap of 280B. Market's wondering about execution of the acquisition. A good match as long as they can execute. Yield is 1.44%. (Analysts’ price target is $100.86)
It reported last night growth, rising market share and accelerating revenue growth. Their best quarter in years. They're buying back stock and paying a good dividend. Their only real problem is handling all the business they're winning.
Is up nearly 40% this year, and is rising much faster than its growth rate. That may not matter--it has the halo effect from being in the dog house for years. It's also cheap compared to its peers.
Oracle is a American stock, trading under the symbol ORCL (previously ORCL-N on Stockchase) on the New York Stock Exchange (ORCL). It is usually referred to as NYSE:ORCL or ORCL
Is Oracle a buy or a sell?
43 expert ratings on Oracle (ORCL) in the last 12 months: 22 Buy, 2 Hold, 19 Sell. Latest rating: PAST TOP PICK by The Panic-Proof Portfolio (Stockchase Research) on Sep 22, 2022. Read the latest stock experts' ratings for Oracle.